PharmaBoardroom

Alper Ureten – VP, General Manager for Biosimilars…

Alper Ureten, Amgen VP and General Manager, sits down with PharmaBoardroom to set out his ambitions and objectives for its Biosimilars Business Unit.…

A Changing View of Sales In Pharma

New approaches to pharma sales: Marrying data analytics with the art of personal engagement The lock-down impact for COVID-19 was stark,…

Carl Laurent – Managing Director, Siemens Healthineers…

Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain Siemens Healthineers’ footprint and…

Cipla to Begin Manufacturing COVID-19 Drug in South Africa

The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this…

Cancer in the USA: A Snapshot

In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments. However, much work remains to be…

China Pharma News Roundup July 24th 2020

A roundup of latest news from Chinese pharma and biotech, including a record high share price for Hansoh, strategic healthcare partnerships, venture…

Axel De Muyt – General Manager & VP, Novo Nordisk…

Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the pharma industry, how he has been able…

William H Lewis – Chairman & CEO, Insmed

William H Lewis, chairman and CEO of serious and rare disease specialist Insmed, talks through the impact of recent product approvals in the US,…

Medicines for Europe Leadership Team on Generics Industry COVID…

In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European…

US Prescription Drug Pricing: “The Times They Are A Changin”

Ulrich Neumann examines the debate around drug pricing in the US and why it is not going away any time soon. Come senators, congressmen…

The End of “Digital” as a Story of Value

John G. Singer examines why technological solutions are not a quick fix to overcoming the COVID-19 crisis and how a systems shift is crucial to…

Bill Sibold – Executive Vice President, Sanofi Genzyme

Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth…

Tagged with